Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Decellularized amniotic membrane hydrogel vs inverted ILM flap for large macular holes

Official title: Comparative Study of Decellularized Human Amniotic Membrane Hydrogel and Inverted Internal Limiting Membrane Flap in Idiopathic Large Macular Holes (MACROHOLE): a Randomized-control Trial

Run by Walailak University · NCT06433284 · Data updated 2026-11-12

This trial tests whether injecting decellularized human amniotic membrane hydrogel can close large macular holes as effectively as the inverted ILM flap technique after vitrectomy.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment26 (estimated)
SponsorWalailak University
Academic / other
Locations1 site (Nakhon Si Thammarat, Thasala)
StatusRecruiting
StartedOctober 1, 2024
Main results expectedAugust 30, 2026
Study endsJanuary 30, 2027
Registry record updatedSeptember 9, 2026
Trial IDNCT06433284 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults with idiopathic full-thickness macular holes larger than 400 µm confirmed on SD-OCT.

Probably not a fit

Patients with very large holes (>1500 µm), traumatic or myopic holes, or co-existing ocular diseases affecting vision may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Participants are adults with idiopathic large macular holes undergoing pars plana vitrectomy. The study randomizes to two surgical approaches: 25-gauge vitrectomy with an inverted ILM flap and SF6 tamponade, or 25-gauge vitrectomy with complete ILM peeling followed by filling the hole with decellularized amniotic membrane hydrogel and SF6 tamponade. Outcomes focus on anatomical hole closure and visual function over approximately six months. The dAM hydrogel is being explored to simplify application and potentially improve healing in large holes. This is a randomized controlled comparison of a novel injectable hydrogel approach versus a surgical tissue flap technique.

Why it matters

Potential benefit: If successful, patients with large macular holes could achieve higher closure rates and better vision with a less technically demanding injectable therapy.

How similar studies have gone: Prior use of human amniotic membrane patches showed high anatomical success, but this study is the first to compare a decellularized membrane hydrogel injectable approach against the inverted ILM flap in a randomized design.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

Age ≥18 years Idiopathic full-thickness macular hole with minimum diameter \>400 µm confirmed on SD-OCT Willing and able to provide written informed consent and comply with 6-month follow-up schedule

Exclusion Criteria:

Full-thickness macular hole with minimum diameter \>1,500 µm Traumatic macular holes Myopic macular holes (axial length \>26.5 mm or refractive error less than -8.0 diopters) Co-existing ocular pathologies independently affecting visual acuity (glaucoma with visual field loss, advanced age-related macular degeneration, diabetic macular edema, or epiretinal membrane requiring surgery) Active intraocular inflammation or infection Previous vitreoretinal surgery Medical unfitness for local anesthesia surgery as determined by the anesthesiologist Inability to maintain prone positioning postoperatively

Where it's running

  • Jakkrit Juhong
    Nakhon Si Thammarat, Thasala, Thailand
    Recruiting

Study contacts

  • Principal investigator: Jakkrit Juhong, MD. — School of Medicine, Walailak university
  • Study coordinator: Jakkrit Juhong, MD.
  • Email: jakkrit.ju@wu.ac.th
  • Phone: +66816773406

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Browse more
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.